DD209735A5 - Verfahren zur herstellung eines neuen arzneimittelpraeparates - Google Patents
Verfahren zur herstellung eines neuen arzneimittelpraeparates Download PDFInfo
- Publication number
- DD209735A5 DD209735A5 DD25091383A DD25091383A DD209735A5 DD 209735 A5 DD209735 A5 DD 209735A5 DD 25091383 A DD25091383 A DD 25091383A DD 25091383 A DD25091383 A DD 25091383A DD 209735 A5 DD209735 A5 DD 209735A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- weight
- indomethacin
- salicylate
- salt
- ulcer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU153582 | 1982-05-14 | ||
| HU153682A HU188167B (en) | 1982-05-14 | 1982-05-14 | Process for producing new pharmaceutical compositions against ulcer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD209735A5 true DD209735A5 (de) | 1984-05-23 |
Family
ID=26317386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD25091383A DD209735A5 (de) | 1982-05-14 | 1983-05-13 | Verfahren zur herstellung eines neuen arzneimittelpraeparates |
Country Status (13)
| Country | Link |
|---|---|
| AR (1) | AR230570A1 (es) |
| AU (1) | AU1459183A (es) |
| BE (1) | BE896711A (es) |
| CA (1) | CA1211374A (es) |
| CH (1) | CH655243A5 (es) |
| DD (1) | DD209735A5 (es) |
| DE (1) | DE3317578A1 (es) |
| DK (1) | DK215883D0 (es) |
| FI (1) | FI831687L (es) |
| FR (1) | FR2527078B1 (es) |
| GB (1) | GB2120938B (es) |
| NL (1) | NL8301722A (es) |
| SE (1) | SE8302689L (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT401727B (de) * | 1989-02-23 | 1996-11-25 | Glaxo Canada | Gelatinekapseln mit einem gehalt an ranitidin (salz) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0189788B1 (de) * | 1985-01-23 | 1989-09-13 | ASTA Pharma Aktiengesellschaft | Synergistische Kombination von Flupirtin und nicht-steroidalen Antiphlogistika |
| US5260333A (en) * | 1986-08-08 | 1993-11-09 | Bristol Myers Squibb Company | Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions |
| GB8625325D0 (en) * | 1986-10-22 | 1986-11-26 | Glaxo Group Ltd | Chemical compounds |
| GB8629781D0 (en) * | 1986-12-12 | 1987-01-21 | Glaxo Group Ltd | Pharmaceutical compositions |
| WO1992015332A1 (en) * | 1991-03-04 | 1992-09-17 | Warner-Lambert Company | Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
| EP0550083B1 (en) * | 1991-12-06 | 1999-03-24 | Glaxo Group Limited | Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate |
| HU213101B (en) * | 1992-12-29 | 1997-02-28 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition of synergetic gastrocitoprotective activity, containing ranitidine and derivative of the salicylic acid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU170329B (es) * | 1974-12-12 | 1977-05-28 | ||
| US4200631A (en) * | 1975-12-17 | 1980-04-29 | Richter Gedeon Vegyeszeti Gyar Rt. | Treating mammalian subject sensitive to indomethacin ulcerogenisis |
| US4198402A (en) * | 1975-12-17 | 1980-04-15 | Richter Gedeon Vegyeszeti Gyar Rt. | Antiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment |
| NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
-
1983
- 1983-05-10 SE SE8302689A patent/SE8302689L/xx not_active Application Discontinuation
- 1983-05-10 CA CA000427820A patent/CA1211374A/en not_active Expired
- 1983-05-10 BE BE0/210740A patent/BE896711A/fr not_active IP Right Cessation
- 1983-05-13 DE DE19833317578 patent/DE3317578A1/de not_active Withdrawn
- 1983-05-13 GB GB08313269A patent/GB2120938B/en not_active Expired
- 1983-05-13 CH CH262683A patent/CH655243A5/de not_active IP Right Cessation
- 1983-05-13 FI FI831687A patent/FI831687L/fi not_active Application Discontinuation
- 1983-05-13 NL NL8301722A patent/NL8301722A/nl not_active Application Discontinuation
- 1983-05-13 DD DD25091383A patent/DD209735A5/de not_active IP Right Cessation
- 1983-05-13 FR FR8307985A patent/FR2527078B1/fr not_active Expired
- 1983-05-13 AR AR29301383A patent/AR230570A1/es active
- 1983-05-13 AU AU14591/83A patent/AU1459183A/en not_active Abandoned
- 1983-05-13 DK DK215883A patent/DK215883D0/da not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT401727B (de) * | 1989-02-23 | 1996-11-25 | Glaxo Canada | Gelatinekapseln mit einem gehalt an ranitidin (salz) |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1211374A (en) | 1986-09-16 |
| GB2120938B (en) | 1985-09-18 |
| AR230570A1 (es) | 1984-05-31 |
| FR2527078A1 (fr) | 1983-11-25 |
| FR2527078B1 (fr) | 1987-06-12 |
| GB2120938A (en) | 1983-12-14 |
| FI831687L (fi) | 1983-11-15 |
| SE8302689D0 (sv) | 1983-05-10 |
| AU1459183A (en) | 1983-11-17 |
| CH655243A5 (de) | 1986-04-15 |
| SE8302689L (sv) | 1983-11-15 |
| DE3317578A1 (de) | 1983-12-01 |
| GB8313269D0 (en) | 1983-06-22 |
| DK215883D0 (da) | 1983-05-13 |
| NL8301722A (nl) | 1983-12-01 |
| BE896711A (fr) | 1983-09-01 |
| FI831687A0 (fi) | 1983-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004010531T2 (de) | Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma | |
| EP0607128B1 (de) | Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen | |
| DE69804281T2 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Leberkrankheiten | |
| DE3346525C2 (de) | Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich | |
| DE3318649A1 (de) | Zweiphasenformulierung | |
| EP1165081B1 (de) | Verfahren zum herstellen tolperison-enthaltender pharmazeutischer zubereitungen zur oralen verabreichung | |
| EP0472501B1 (de) | Codeinsalz einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und pharmazeutische Präparate | |
| DE4201903B4 (de) | Pharmazeutische Verwendung von Boswelliasäuren | |
| DE1802394C2 (de) | Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten | |
| DE69635298T2 (de) | Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen | |
| DD209735A5 (de) | Verfahren zur herstellung eines neuen arzneimittelpraeparates | |
| EP0147735A2 (de) | Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen | |
| DE3739779A1 (de) | Pharmazeutische praeparate | |
| DE69630073T2 (de) | (-)Hydroxycitrat enthaltende Verbindungen mit neuen therapeutischen Wirkungen | |
| DD242349A5 (de) | Verfahren zur herstellung einer synergistischen kombination von flupirtin und 4-acetamido-phenol | |
| DE2342460A1 (de) | Eisen- oder aluminiumglycyrrhizinat enthaltendes produkt, verfahren zu seiner herstellung und dieses produkt enthaltendes arzneimittel | |
| EP0301373B1 (de) | Erzeugnisse, enthaltend Gallopamil und Prazosin | |
| DE2605243A1 (de) | Pyrazolessigsaeurehaltiges arzneimittel | |
| EP0484581B1 (de) | Verwendung von Thromboxan-A2-Antagonisten zur Verhinderung von degenerativen Vorgängen im penilen Gewebe | |
| DE3306299C2 (es) | ||
| DE19911371A1 (de) | Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen | |
| EP0253293B1 (de) | Neue Guanidiniumasparaginate | |
| DE69426317T2 (de) | Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation | |
| DE2638554A1 (de) | Choleretika | |
| DE3901508C2 (de) | Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |